Literature DB >> 19039597

Accumulation of phosphorylated TDP-43 in brains of patients with argyrophilic grain disease.

Hiroshige Fujishiro1, Hirotake Uchikado, Tetsuaki Arai, Masato Hasegawa, Haruhiko Akiyama, Osamu Yokota, Kuniaki Tsuchiya, Takashi Togo, Eizo Iseki, Yoshio Hirayasu.   

Abstract

To determine whether TAR-DNA binding protein 43 (TDP-43) immunoreactivity was present in brains of argyrophilic grain disease (AGD), we immunohistochemically examined 15 cases of AGD (mean age at death: 84 years) using a panel of anti-TDP-43 antibodies, including both phosphorylation-independent and -dependent ones. Nine AGD cases (60%) showed TDP-43 immunoreactivities mainly in the limbic regions and lateral occipitotemporal cortex. TDP-43 positive structures included neuronal cytoplasmic inclusions, dystrophic neurites, glial cytoplasmic inclusions, grain-like dot-shaped structures, and neurofibrillary tangle (NFT)-like structures. The distribution of these TDP-43 positive structures was largely consistent with that of argyrophilic grains. Double-labeling confocal microscopy revealed, however, that many of phospho-TDP-43 positive structures were not colocalized with phospho-tau staining. Colocalization of phospho-TDP-43 and phospho-tau was observed only in part of neuronal cytoplasmic inclusions, grain-like structures and NFT-like structures. There were no differences in demographics, disease duration, brain weight, NFT Braak stage, or severity of amyloid burden between AGD cases with and without TDP-43-immunoreactivity. However, cases of AGD with TDP-43-immunoreactivity were assigned to higher AGD stages than those without TDP-43-immunoreactivity (P < 0.05). Furthermore, the TDP-43 pathology tended to be prominent in cases with severe grain pathology. The results of the present study indicate for the first time a high frequency of concomitant TDP-43 pathology in AGD, and suggest that abnormal accumulation of TDP-43 may be involved in the pathological process and disease progression of AGD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19039597     DOI: 10.1007/s00401-008-0463-2

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  42 in total

Review 1.  On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia.

Authors:  F Geser; D Prvulovic; L O'Dwyer; O Hardiman; P Bede; A L W Bokde; J Q Trojanowski; H Hampel
Journal:  Prog Neurobiol       Date:  2011-09-03       Impact factor: 11.685

Review 2.  TDP-43 Prions.

Authors:  Takashi Nonaka; Masato Hasegawa
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

3.  Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype.

Authors:  Shunsuke Koga; Naomi Kouri; Ronald L Walton; Mark T W Ebbert; Keith A Josephs; Irene Litvan; Neill Graff-Radford; J Eric Ahlskog; Ryan J Uitti; Jay A van Gerpen; Bradley F Boeve; Adam Parks; Owen A Ross; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2018-06-20       Impact factor: 17.088

4.  Molecular dissection of TDP-43 proteinopathies.

Authors:  Masato Hasegawa; Takashi Nonaka; Hiroshi Tsuji; Akira Tamaoka; Makiko Yamashita; Fuyuki Kametani; Mari Yoshida; Tetsuaki Arai; Haruhiko Akiyama
Journal:  J Mol Neurosci       Date:  2011-06-16       Impact factor: 3.444

5.  Antemortem volume loss mirrors TDP-43 staging in older adults with non-frontotemporal lobar degeneration.

Authors:  Alexandre Bejanin; Melissa E Murray; Peter Martin; Hugo Botha; Nirubol Tosakulwong; Christopher G Schwarz; Matthew L Senjem; Gael Chételat; Kejal Kantarci; Clifford R Jack; Bradley F Boeve; David S Knopman; Ronald C Petersen; Caterina Giannini; Joseph E Parisi; Dennis W Dickson; Jennifer L Whitwell; Keith A Josephs
Journal:  Brain       Date:  2019-11-01       Impact factor: 13.501

6.  TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease.

Authors:  Eileen H Bigio; Manjari Mishra; Kimmo J Hatanpaa; Charles L White; Nancy Johnson; Alfred Rademaker; Bing Bing Weitner; Han-Xiang Deng; Steven D Dubner; Sandra Weintraub; Marsel Mesulam
Journal:  Acta Neuropathol       Date:  2010-04-02       Impact factor: 17.088

7.  TDP-43 Neuropathologic Associations in the Nun Study and the Honolulu-Asia Aging Study.

Authors:  Margaret E Flanagan; Brenna Cholerton; Caitlin S Latimer; Laura S Hemmy; Steven D Edland; Kathleen S Montine; Lon R White; Thomas J Montine
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 8.  Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases.

Authors:  Felix Geser; Maria Martinez-Lage; Linda K Kwong; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Neurol       Date:  2009-03-07       Impact factor: 4.849

9.  TARDBP 3'-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathy.

Authors:  Michael A Gitcho; Eileen H Bigio; Manjari Mishra; Nancy Johnson; Sandra Weintraub; Marsel Mesulam; Rosa Rademakers; Sumi Chakraverty; Carlos Cruchaga; John C Morris; Alison M Goate; Nigel J Cairns
Journal:  Acta Neuropathol       Date:  2009-07-18       Impact factor: 17.088

Review 10.  Molecular neuropathology of TDP-43 proteinopathies.

Authors:  Manuela Neumann
Journal:  Int J Mol Sci       Date:  2009-01-09       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.